To develop a genome-editing strategy that minimizes immune response and enhances gene insertion efficiency.
Key Findings:
INSTALL enables high-fidelity DNA integration across multiple recombinase systems.
Improved efficiency in human cells and better tolerability in mice compared to traditional dsDNA methods.
INSTALL-treated animals exhibited minimal inflammation and sustained integration, unlike dsDNA which caused severe immune activation.
Interpretation:
INSTALL represents a significant advancement in genome editing by combining immune-evasive nucleic acids with precise recombinase technology, potentially broadening the applications of gene insertion.
Limitations:
Further studies are needed to fully understand long-term effects and safety in humans.
The scalability and practical applications in clinical settings require additional validation.
Conclusion:
INSTALL offers a promising non-viral approach to in vivo genome writing, potentially expanding therapeutic options for gene insertion technologies.
